[The clinical relationship between XXXX with or without @entity480 ].

@entity1 @entity2023 @entity102 @entity56 @entity480
OBJECTIVE: To investigate the clinical relationship between @entity2023 and @entity56 with chronic rhinosinusitis with or without @entity480 . METHOD: Two hundred @entity1 were divided into A and B two groups. Group A of 110 @entity1 was diagnosed @entity2023 . Group B of 90 @entity1 was diagnosed @entity102 with or without @entity480 . Serums sIgE was detected with EUROIMMUN, and observe the recurrence rate of @entity102 with or without @entity480 @entity1 who accept operation treatment and observe the incidence of @entity2023 superinduced @entity102 with or without @entity480 . RESULT: The total positive rate of group A sIgE was 89.09%. The total positive rate of group B sIgE was 74.44%. The postoperative recurrence rate of sIgE positive group was 58.21% and the postoperative recurrence rate of sIgE negative group was 8.70% in the group B. In the group A, the positive rate of serums sIgE in @entity2023 with @entity102 with or without @entity480 (37.27%) was 97.56%, while the positive rate of serums sIgE in @entity2023 without @entity102 (62.73%) was 79.71%, there is a significant difference in @entity2023 with or without @entity102 (  2 = 6.96, P < 0.01). CONCLUSION: There is a certain correlation between @entity2023 and @entity56 with @entity102 with or without @entity480 . Therefore, through avoiding allergen exposure, the treatment of @entity2023 can effectively control recurrence rate of @entity102 and @entity480 .
